IPG
56
3
DG
6
2
SYY
53
4
HPQ
63
6
GOOG
50
-3
AON
54
2
INTC
33
-2
EL
25
4
MSFT
50
3
COF
60
2
BA
54
5
A
43
2
NTAP
67
-3
AN
58
4
SE
61
-4
KMB
39
2
DHI
48
4
MET
72
5
GOOGL
40
-5
LB
63
22
IPG
56
3
DG
6
2
SYY
53
4
HPQ
63
6
GOOG
50
-3
AON
54
2
INTC
33
-2
EL
25
4
MSFT
50
3
COF
60
2
BA
54
5
A
43
2
NTAP
67
-3
AN
58
4
SE
61
-4
KMB
39
2
DHI
48
4
MET
72
5
GOOGL
40
-5
LB
63
22
Financhill
Back

Catheter Precision Vs. Perspective Therapeutics Industry Stock Comparison

Buy
55

VTAK
Catheter Precision

Last Price:
0.42
Seasonality Move:
-2.72%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Buy
55
Catheter Precision (VTAK) is a Buy

Is Catheter Precision a Buy, Sell or Hold?

  • The current Catheter Precision [VTAK] share price is $0.42. The Score for VTAK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • VTAK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VTAK Stock Price Chart

What is Catheter Precision's stock price today?

  • The Catheter Precision share price today is $0.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VTAK is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

VTAK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 40.87 Sell
Chaikin Money Flow: -14256 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.4 - 0.7) Sell
Bollinger Bands (100): (0.18 - 2.22) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

VTAK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.45 Sell
20-day SMA: 0.48 Sell
50-day SMA: 0.49 Sell
200-day SMA: 3.17 Sell
8-day EMA: 0.44 Sell
20-day EMA: 0.48 Sell
50-day EMA: 0.69 Sell
200-day EMA: 4.95 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Catheter Precision Earnings Growth & VTAK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.46 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.26 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Catheter Precision Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):